Showing results (2371-2380 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|April 28, 2009
Acute left ventricular dysfunction induced by a panHER and VEGFR tyrosine kinase inhibitor in a phase I trialRastislav Bahleda, Christophe Massard, Jean-Charles Soria, et al.
Investigational New Drugs|October 23, 2008
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)Robert P Whitehead, Cathryn Rankin, Paulo M G Hoff, et al.
Investigational New Drugs|January 14, 2009
Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcoholClovis O Da Fonseca, Julio Thome Silva, Igor Rodrigo Lins, et al.
Investigational New Drugs|May 1, 1991
Pharmacokinetics of 2',3'-dideoxyadenosine in dogsM G Wientjes, M E Placke, M J Chang, et al.
Investigational New Drugs|October 9, 2008
A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancerBryan H Burmeister, Euan T Walpole, Nancy D'Arcy, et al.
Investigational New Drugs|October 15, 2008
Characterization of the cytotoxic activity of the indoloquinoline alkaloid cryptolepine in human tumour cell lines and primary cultures of tumour cells from patientsDaniel Laryea, Anders Isaksson, Colin W Wright, et al.
Investigational New Drugs|January 17, 2009
The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drugMiguel Muñoz, Marisa Rosso
Investigational New Drugs|July 14, 2005
A study of cytotoxic synergy of UCN-01 and flavopiridol in syngeneic pair of cell linesKongming Wu, Mark D'Amico, Chenguang Wang, et al.
Investigational New Drugs|July 14, 2005
Phase II study of CCI-779 in patients with recurrent glioblastoma multiformeSusan M Chang, Patrick Wen, Timothy Cloughesy, et al.
Investigational New Drugs|July 14, 2005
Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II studyNicolas Tsavaris, Christos Kosmas, Helias Skopelitis, et al.
Pageof 372